News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
New Treatment Option for H3 K27M-Mutant Glioma Treatment – Jazz Pharmaceuticals
Aug 7, 2025, 14:24

New Treatment Option for H3 K27M-Mutant Glioma Treatment – Jazz Pharmaceuticals

Jazz Pharmaceuticals shared a post on LinkedIn:

“H3 K27M-mutant diffuse midline glioma is an ultra-rare, aggressive brain cancer that has historically been marked by limited treatment options and poor prognoses.

Today’s approval represents an important advancement for patients and caregivers impacted by this difficult-to-treat disease by offering them a new treatment option.

The collaborative efforts that culminated in this meaningful achievement showcase our dedication to innovation to help meet the needs of patients and their families.”

More posts featuring Jazz Pharmaceuticals on OncoDaily.

brain cancer cancer cancer treatment Diffuse Midline Glioma glioma H3 K27M Glioma Jazz Pharmaceuticals OncoDaily Oncology
Special Coverage
Science
Aug 25, 2025, 09:45
Myeloma Paper of the Day, August 25th, Suggested by Robert Orlowski
Voices
Aug 25, 2025, 09:35
Abdu Adem Yesufe: SPHMMC LINAC Installation Is Complete - A Milestone for Patient Care
Techology
Aug 25, 2025, 09:21
Olivier Elemento: A New Paradigm for Data Interaction - Combining Voice and Augmented Reality
Voices
Aug 25, 2025, 09:09
Caryn Lerman: USC Norris Showcases Future Leaders in Cancer Research
Positive
Aug 25, 2025, 09:01
Joanna Metzner-Sadurski: Historic 50 Million Dollar Anonymous Gift to the Medical University of South Carolina
Voices
Aug 25, 2025, 08:49
Narjust Florez: Boston City Councilor Explores the EQUAL Lung Cancer Screening Study
Voices
Aug 25, 2025, 08:46
Vivek Subbiah: Health-Related Quality of Life in KRASG12C-Mutated Colorectal Cancer
Dialogues
Aug 25, 2025, 06:21
Balstilimab and Botensilimab insights with Dr Benjamin Shelchter - Latest MSS CRC Data from ESMO GI
Voices
Aug 24, 2025, 21:47
Pat Garcia-Gonzalez: One Year of Breast Cancer Program Success in Kenya
Voices
Aug 24, 2025, 21:22
Gustavo Viani: Time to Rethink Brain Metastasis Management
Career Updates
Aug 24, 2025, 19:55
Evelyn Wong is Starting a New Position as Senior Clinical Fellow at University College London Hospitals NHS Foundation Trust
Voices
Aug 24, 2025, 19:46
Haimanot Kasahun: Reflections on Ethiopia’s Radiation Expansion Journey